Literature DB >> 24648518

C-terminal Src kinase (Csk)-mediated phosphorylation of eukaryotic elongation factor 2 (eEF2) promotes proteolytic cleavage and nuclear translocation of eEF2.

Qi Yao1, Bing-Qian Liu, Hui Li, Deirdre McGarrigle, Bo-Wen Xing, Mao-Tian Zhou, Zhe Wang, J Jillian Zhang, Xin-Yun Huang, Lin Guo.   

Abstract

Protein-tyrosine kinase C-terminal Src kinase (Csk) was originally purified as a kinase for phosphorylating Src and other Src family kinases. The phosphorylation of a C-terminal tyrosine residue of Src family kinases suppresses their kinase activity. Therefore, most physiological studies regarding Csk function have been focused on Csk as a negative regulator of Src family tyrosine kinases and as a potential tumor suppressor. Paradoxically, the protein levels of Csk were elevated in some human carcinomas. In this report, we show that eukaryotic elongation factor 2 (eEF2) is a new protein substrate of Csk and could locate in the nucleus. We demonstrate that Csk-mediated phosphorylation of eEF2 has no effect on its cytoplasmic function in regulating protein translation. However, phosphorylation of eEF2 enhances its proteolytic cleavage and the nuclear translocation of the cleaved eEF2 through a SUMOylation-regulated process. Furthermore, we show that cleaved fragments of eEF2 can induce nuclear morphological changes and aneuploidy similar to those in cancer cells, suggesting that there is an additional mechanism for Csk in tumorigenesis through regulation of eEF2 subcellular localization.

Entities:  

Keywords:  Cancer Biology; Csk; Nuclear Pleomorphism; Nuclear Translocation; Phosphorylation; Proteolytic Cleavage; Sumoylation; Translation Elongation Factors

Mesh:

Substances:

Year:  2014        PMID: 24648518      PMCID: PMC4007456          DOI: 10.1074/jbc.M113.546481

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  PDSM, a motif for phosphorylation-dependent SUMO modification.

Authors:  Ville Hietakangas; Julius Anckar; Henri A Blomster; Mitsuaki Fujimoto; Jorma J Palvimo; Akira Nakai; Lea Sistonen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

2.  Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).

Authors:  Sungsoo Lee; Marina K Ayrapetov; David J Kemble; Keykavous Parang; Gongqin Sun
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

3.  Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc.

Authors:  Zihao Wang; Marjan Gucek; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

4.  Domain interactions in protein tyrosine kinase Csk.

Authors:  D Sondhi; P A Cole
Journal:  Biochemistry       Date:  1999-08-24       Impact factor: 3.162

5.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

6.  eEF1A is a novel component of the mammalian nuclear protein export machinery.

Authors:  Mireille Khacho; Karim Mekhail; Karine Pilon-Larose; Arnim Pause; Jocelyn Côté; Stephen Lee
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

7.  The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src.

Authors:  Chitose Oneyama; Tomoya Hikita; Kengo Enya; Marc-Werner Dobenecker; Kazunobu Saito; Shigeyuki Nada; Alexander Tarakhovsky; Masato Okada
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

8.  Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.

Authors:  Junya Nakamura; Sayaka Aoyagi; Isamu Nanchi; Shin-Ichi Nakatsuka; Erika Hirata; Shohei Shibata; Mari Fukuda; Yumiko Yamamoto; Ikuyo Fukuda; Naoya Tatsumi; Tazu Ueda; Fumihiro Fujiki; Masaya Nomura; Sumiyuki Nishida; Toshiaki Shirakata; Naoki Hosen; Akihoro Tsuboi; Yoshihiro Oka; Riichiro Nezu; Masaki Mori; Yuichiro Doki; Katsuyuki Aozasa; Haruo Sugiyama; Yusuke Oji
Journal:  Int J Oncol       Date:  2009-05       Impact factor: 5.650

9.  Proteomic study on X-irradiation-responsive proteins and ageing: search for responsible proteins for radiation adaptive response.

Authors:  Yuri Miura; Mayumi Kano; Masaki Yamada; Tsutomu Nishine; Shiro Urano; Shozo Suzuki; Tamao Endo; Tosifusa Toda
Journal:  J Biochem       Date:  2007-05-23       Impact factor: 3.387

10.  Structural basis for the recognition of c-Src by its inactivator Csk.

Authors:  Nicholas M Levinson; Markus A Seeliger; Philip A Cole; John Kuriyan
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

View more
  7 in total

1.  Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.

Authors:  James D West; Erica J Carrier; Nathaniel C Bloodworth; Alison K Schroer; Peter Chen; Larisa M Ryzhova; Santhi Gladson; Sheila Shay; Joshua D Hutcheson; W David Merryman
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

2.  Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.

Authors:  Leona L Pott; Sascha Hagemann; Henning Reis; Kristina Lorenz; Thilo Bracht; Thomas Herold; Boris V Skryabin; Dominik A Megger; Julia Kälsch; Frank Weber; Barbara Sitek; Hideo A Baba
Journal:  Oncotarget       Date:  2017-02-14

3.  Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation.

Authors:  Hui Li; Qi Yao; Alberto Garcia Mariscal; Xudong Wu; Justus Hülse; Esben Pedersen; Kristian Helin; Ari Waisman; Caroline Vinkel; Simon Francis Thomsen; Alexandra Avgustinova; Salvador Aznar Benitah; Paola Lovato; Hanne Norsgaard; Mette Sidsel Mortensen; Lone Veng; Björn Rozell; Cord Brakebusch
Journal:  Nat Commun       Date:  2018-04-12       Impact factor: 14.919

4.  C-terminal Src kinase (Csk) regulates the tricellular junction protein Gliotactin independent of Src.

Authors:  G D N Gayathri Samarasekera; Vanessa Jane Auld
Journal:  Mol Biol Cell       Date:  2017-11-22       Impact factor: 4.138

5.  SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function.

Authors:  Nan Cui; Tianqi Liu; Yanmin Guo; Jinzhuo Dou; Qianqian Yang; Hailong Zhang; Ran Chen; Yanli Wang; Xian Zhao; Jianxiu Yu; Jian Huang
Journal:  Neoplasia       Date:  2019-05-21       Impact factor: 5.715

Review 6.  Localization and Functional Roles of Components of the Translation Apparatus in the Eukaryotic Cell Nucleus.

Authors:  Zaur M Kachaev; Sergey D Ivashchenko; Eugene N Kozlov; Lyubov A Lebedeva; Yulii V Shidlovskii
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

7.  C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.

Authors:  Yoshie Senda; Naoko Murata-Kamiya; Masanori Hatakeyama
Journal:  Cancer Sci       Date:  2016-06-13       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.